Postmenopausal hair loss: causes, treatment and the chances of regrowth

Why does hair change after menopause?

Hormonal changes can affect the hair cycle, including the proportion of follicles actively producing hair. Oestrogen plays a part, although its precise effects and those of androgens in female hair loss remain incompletely understood. The review by Kamp and colleagues describes hormonal changes alongside ageing and genetic susceptibility.

Women can develop female pattern hair loss while their androgen levels remain within the normal range. Thinner hair does not prove that testosterone is too high, and normal hormone tests do not rule out this condition. A family history provides useful context without predicting exactly how an individual’s hair will change.

Female pattern hair loss becomes more common with age, but studies involve different populations and diagnostic criteria. A single percentage cannot reliably describe every postmenopausal woman. The distribution of thinning, its speed of onset and the condition of the scalp are more useful for deciding what to investigate than comparison with an average.

Which signs help distinguish the main causes?

A parting that gradually becomes wider

Female pattern hair loss involves progressive reduction in the thickness of individual hairs, known as miniaturisation. Hair becomes less dense over the top of the scalp and the central parting widens, often with the frontal hairline preserved. The process can begin before menopause and become more noticeable afterwards.

An examination looks for variation in hair diameter and assesses where thinning has developed. Our explanation of androgenetic alopecia covers this process in more detail. Increased shedding can occur alongside pattern hair loss, so a consultation may identify more than one contributing condition.

Widespread shedding that starts relatively quickly

Telogen effluvium can follow a feverish illness, surgery, substantial weight loss or a distressing event. An unusually large number of follicles enter the resting phase, with increased shedding becoming apparent a few months later. The widespread distribution and timing help guide assessment, although neither establishes the diagnosis alone.

Telogen effluvium usually preserves the follicles and can improve once the trigger has resolved. However, it may persist or reveal underlying pattern hair loss that was previously less noticeable. Continuing shedding therefore deserves reassessment, even when a stressful episode initially seems to explain it.

A receding hairline with thinning eyebrows

A widening band of hair loss across the forehead or temples, particularly with eyebrow thinning, raises the possibility of frontal fibrosing alopecia. Redness around individual hairs, scaling, itching or discomfort may accompany it. The condition can also progress without prominent symptoms.

This is a form of scarring alopecia in which inflammation can destroy follicles. It affects many postmenopausal women but also occurs in other groups. Early dermatological assessment allows treatment aimed at limiting further loss; follicles that have been destroyed can no longer produce hair.

When should you see a doctor, and what does assessment involve?

Arrange a GP appointment if your hair is becoming thinner, the shedding worries you or it affects your wellbeing. Recent hairline recession, eyebrow loss, scalp pain or red, scaly skin should be assessed without waiting months for improvement. Clearly defined bald patches also need investigation for other forms of alopecia.

The clinician asks when the changes began, how they have progressed, and about recent illness and medication. Examination covers different areas of the scalp and may include magnification with a device used for trichoscopy. A dermatologist may recommend a scalp biopsy if scarring disease is suspected or the diagnosis remains uncertain.

Blood tests are selected according to the examination and medical history. A full blood count, ferritin and thyroid tests may help investigate diffuse shedding; a full panel of vitamin or hormone tests is not automatically required. New, rapidly increasing facial hair, unusual acne or a change in voice should be mentioned because these findings can guide hormonal assessment.

Bring a list of prescriptions and supplements, together with older photographs if available. Explain any medication changes around menopause and whether you have followed a restrictive diet. Photographs taken with similar lighting and the same parting can help document changes more reliably than trying to estimate every hair shed each day.

Can minoxidil help improve hair density?

For confirmed female pattern hair loss, minoxidil applied to the scalp is an established treatment option. The review by Ramos and colleagues identifies it as the first choice on the strength of the available evidence. It can improve growth in some follicles and reduce progressive thinning, although the response varies between individuals.

Assessment requires consistent use over time, with initial changes generally sought after four to six months. A temporary increase in shedding can occur when treatment starts. A pharmacist or prescribing clinician should explain which formulation is suitable and how to use it, because licensed indications and available strengths vary between products and countries.

Possible unwanted effects include scalp irritation, itching and facial hair growth. Contact the professional overseeing treatment if tolerability becomes a problem or increased shedding continues. When minoxidil helps, ongoing treatment is usually needed to retain its benefit; stopping can lead to gradual loss of the improvement achieved.

Agree what treatment is intended to achieve, whether that is stabilising the parting, reducing shedding or improving a particular area. Comparable photographs help assess progress without changing products in response to every visual fluctuation. Telogen effluvium and scarring alopecia require different management priorities, which is why confirming the cause matters before starting treatment.

What role do HRT and oral medicines have?

Hormone replacement therapy, or HRT, is not an established treatment for female pattern hair loss. Kamp and colleagues found insufficient evidence to support its use for that purpose. Decisions about HRT should address menopausal symptoms, medical history and the individual’s balance of benefits and risks.

If shedding starts after a change in hormone treatment, explain the timing to your GP or menopause clinician. They can assess whether there may be a connection and consider other explanations. Starting, changing or stopping HRT solely because of a claim about hair regrowth would be inappropriate.

A dermatologist may sometimes consider oral minoxidil or a medicine with antiandrogen effects, depending on the diagnosis and previous treatment. Such prescribing may be outside the medicine’s licensed indication for female hair loss and requires a specific discussion. Oral minoxidil can cause increased body hair, swelling or palpitations; spironolactone requires assessment of blood pressure and the risk of abnormal potassium levels.

Being postmenopausal does not automatically make these medicines suitable. Heart or kidney disease, other prescriptions and contraindications influence both selection and monitoring. Evidence from treatments for male pattern baldness cannot simply be transferred to women, as the 2023 therapeutic review emphasises.

Do vitamins, haircare and natural products help?

An adequate, varied diet supports the nutritional requirements of hair. When a deficiency is identified, the clinician investigates its cause and recommends appropriate correction. Taking iron, zinc or vitamin supplements without an indication does not establish that hair loss will improve.

The review by Almohanna and colleagues highlights the lack of convincing evidence for biotin in people without deficiency. Supplements can also cause difficulties: biotin interferes with some blood tests, while excessive vitamin A can contribute to shedding. Show your healthcare professional the packaging or ingredient list of products you already take.

Gentle haircare mainly helps protect the hair shaft and reduce breakage. Using less heat, limiting harsh chemical processing and avoiding tightly pulled hairstyles can protect fragile lengths. Volumising shampoo may improve how the hair looks, but this cosmetic effect does not demonstrate that follicles are producing more hair.

Natural oils and serums should also be assessed according to their ingredients and tolerability. Describing a product as natural establishes neither effectiveness for postmenopausal hair loss nor freedom from irritation. A haircare routine can accompany the chosen treatment, provided it does not delay assessment when thinning continues to progress.

What can PRP and light devices offer?

Platelet-rich plasma, or PRP, involves injecting a preparation made from the person’s blood, containing concentrated platelets, into the scalp. Trials discussed by Ramos and colleagues suggest possible benefit for some pattern hair loss, with limitations including small samples and differing protocols. It is an option for individual discussion after the diagnosis has been established.

Photobiomodulation uses low-intensity light from devices with varying technical specifications. Studies report improvements in density, but their findings cannot be assumed to apply equally to every cap, comb or other device. Before purchasing one or arranging sessions, ask which evidence relates specifically to the proposed device and your diagnosed condition.

Comparing these options also requires clarity about the planned sessions, overall cost and how progress will be assessed. Treatments described as regeneration or cellular micrografts need clinical evidence for the exact procedure, beyond its branding. Menopause alone is not enough information to select a procedure.

When might a hair transplant be appropriate?

Transplantation may be considered for selected, sufficiently stable cases of female pattern hair loss when the back of the scalp retains suitable hair. The surgeon compares the density and calibre in this donor area with those in the intended recipient area. If thinning also affects the regions used for harvesting, the available supply may be too limited to produce a worthwhile improvement.

A transplant redistributes follicles and does not, by itself, manage continuing pattern hair loss. Active telogen shedding or an inflammatory scarring condition takes the priority back to medical assessment and treatment. Any consideration of surgery for frontal fibrosing alopecia requires specialist selection, because reactivation remains possible after a period of apparent stability.

The implantation method is chosen after these questions have been addressed. Using an implanter pen, often described as DHI, cannot compensate for inadequate donor hair or remove the scars caused by harvesting. Our guide to hair transplantation for women helps prepare questions about shaving, achievable coverage and follow-up.

How can you move forward with realistic expectations?

Temporary shedding may be followed by gradual recovery, whereas female pattern hair loss often needs ongoing management. The potential improvement also depends on how long thinning has been present and the condition of the follicles. Follow-up assesses progress, tolerability and useful adjustments, without promising a return to previous density.

Hair fibres, a suitable hairstyle or a hairpiece may help with appearance during this process. The emotional impact deserves discussion even if the loss appears limited on examination. The NHS notes that a GP may help arrange counselling when hair loss causes distress, and that some treatments involve private costs.

If assessment identifies a suitable surgical indication, our team can explain the preparation involved in a hair transplant in Istanbul. Provide the dermatological findings and details of current treatment so the practitioners can consider your individual circumstances. The discussion should address priority areas, the limits of the proposed procedure and arrangements for follow-up.

Sources

Kamp, E., Ashraf, M., Musbahi, E., & DeGiovanni, C. (2022). Menopause, skin and common dermatoses. Part 1: hair disorders. Clinical and Experimental Dermatology, 47(12), 2110-2116. https://doi.org/10.1111/ced.15327

Ramos, P. M., Melo, D. F., Radwanski, H., de Almeida, R. F. C., & Miot, H. A. (2023). Female-pattern hair loss: therapeutic update. Anais Brasileiros de Dermatologia, 98(4), 506-519. https://doi.org/10.1016/j.abd.2022.09.006

Porriño-Bustamante, M. L., Fernández-Pugnaire, M. A., & Arias-Santiago, S. (2021). Frontal fibrosing alopecia: A review. Journal of Clinical Medicine, 10(9), 1805. https://doi.org/10.3390/jcm10091805

Malkud, S. (2015). Telogen effluvium: A review. Journal of Clinical and Diagnostic Research, 9(9), WE01-WE03. https://doi.org/10.7860/JCDR/2015/15219.6492

Almohanna, H. M., Ahmed, A. A., Tsatalis, J. P., & Tosti, A. (2019). The role of vitamins and minerals in hair loss: A review. Dermatology and Therapy, 9(1), 51-70. https://doi.org/10.1007/s13555-018-0278-6

National Health Service. (2024). Hair loss. https://www.nhs.uk/symptoms/hair-loss/